PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Liquid paraffin
Presentation Product Chemical substance Chapter Items dispensed
Doublebase emollient bath additive
1302011M0BKAAAI
Doublebase Liquid paraffin Skin 3,572
Lacri-lube eye ointment
1108010L0BBAAAB
Lacri-lube Liquid paraffin Eye 3,387
Emulsiderm emollient
1302011M0BBAAAE
Emulsiderm Liquid paraffin Skin 2,345
Dermalo bath emollient
1302011M0BIAAAG
Dermalo Liquid paraffin Skin 2,201
Liquid paraffin liquid
0106030P0AAABAB
Liq paraf (Systemic) Liquid paraffin Gastro-Intestinal System 375
Liquid paraffin 65% bath additive
1302011M0AAAIAI
Liquid paraffin Liquid paraffin Skin 201
Liquid paraffin 65% / Acetylated wool alcohols 5% bath oil
1302011M0AAAGAG
Liquid paraffin Liquid paraffin Skin 195
Generic Emulsiderm emollient
1302011M0AAAEAE
Liquid paraffin Liquid paraffin Skin 2
Alpha Keri bath oil
1302011M0BFAAAA
Alpha Keri Liquid paraffin Skin No data available
Ashbourne Emollient Medicinal bath oil
1302011M0BJAAAG
Ashbourne (Emollient) Liquid paraffin Skin No data available
Generic Lubri-tears eye ointment
1108010L0AAADAD
Liquidparaffin (Eye) Liquid paraffin Eye No data available
Liquid paraffin 91.7% / Lanolin 3% bath oil
1302011M0AAAAAA
Liquid paraffin Liquid paraffin Skin No data available
Liquid paraffin eye drops
1108010L0AAAAAA
Liquidparaffin (Eye) Liquid paraffin Eye No data available
Liquid paraffin light eye drops
1108010L0AAACAC
Liquidparaffin (Eye) Liquid paraffin Eye No data available
Liquid paraffin oral emulsion
0106030P0AAAAAA
Liq paraf (Systemic) Liquid paraffin Gastro-Intestinal System No data available
Lubri-Tears eye ointment
1108010L0BDAAAD
Lubri-Tears Liquid paraffin Eye No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.